Articles

New Advances in the Management of Refractory Angina Pectoris

Kevin Cheng, Ranil de Silva

European Cardiology Review 2018;13(1):ePub:23 June 2018.

DOI: https://doi.org/10.15420/ecr.2018:1:2
Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator

Hiroshi Watanabe

European Cardiology Review 2018;13(1):ePub:16 May 2018.

DOI: https://doi.org/10.15420/ecr.2017:22:2
Intravascular Ultrasound-guided Management of Diffuse Stenosis

Philip Dingli, Nieves Gonzalo, Javier Escaned

Radcliffe Cardiology Review 2018:1–18.
Analysis of Factors Associated with Smoking Relapse

Sayaka Shimada, Maki Komiyama, Hiromichi Wada, Hajime Yamakage, Akira Shimatsu, Yuko Takahashi, Koji Hasegawa

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure

Masafumi Funamoto, Yoichi Sunagawa, Yasufumi Katanasaka, Yusuke Miyazaki, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Choice of Anticoagulation Therapy in Atrial Patients with Rate Control and Rhythm Control Strategy - Data from a Multicenter Real-life Registry

Anna E Platek, Anna Hrynkiewicz-Szymanska, Anna Rys, Karolina Semczuk, Filip M Szymanski, Krzysztof J Filipiak

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Prospective and Centralized Follow-Up of a Territorial Protocol of Use of Direct Oral Anticoagulants in Non Valvular Atrial Fibrillation

Fernando Worner, Cristina Marzo, Kristian Rivera, Nuria Sans, Ainara Ferrero, Joan Antoni Schoenenberger, Leonardo Galván, Albina Aldomà

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine- Induced Responses in Cardiomyocytes

Mai Genpei, Yoichi Sunagawa, Masafumi Funamoto, Kana Shimizu, Yusuke Miyazaki, Yasufumi Katanasaka, Nobuaki Takahashi, Hideaki Kakeya, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo

Kana Shimizu, Masafumi Funamoto, Mai Genpei, Yoichi Sunagawa, Yasufumi Katanasaka, Yusuke Miyazaki, Hiroyuki Shibata, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure

Yoichi Sunagawa, Masafumi Funamoto, Anna Suzuki, Kana Shimizu, Ryoga Sakurai, Yasufumi Katanasaka, Yusuke Miyazaki, Tomohiro Asakawa, Toshiyuki Kan, Junya Inagaki, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time

Kristian Rivera, Cristina Marzo, Nuria Sans, Ainara Ferrero, Albina Aldomà, Joan Antoni Schoenenberger, Leonardo Galván, Fernando Worner

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

Mario DiazNuila Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, Pablo Del Castillo-Vásquez, Walter Bragagnini, Fadwa Taibi, Carlos Roca-Gutiérrez, Joan Carles Oliva-Morera, Eduardo Bosch-Peligero, Josep Guindo-Soldevila, Antoni Martínez-Rubio

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used

Pablo Del Castillo-Vásquez, Núria Casanovas, Marcel Santaló-Corcoy, Fernando Narro, Ana Paula Caresia, Ana Barradas, Walter Bragagnini, Joan Carles Martin, Laura Guillamon, Lluís Bernà, Antoni Martínez-Rubio

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
External 30 Days Holter Usefulness in Unexplained Syncope, Palpitations and Cardioembolic Suspected Cryptogenic Stroke Study

Miriam García Bermúdez, Antonia Ortega Diaz, Ana Bonet Basiero, Antoni Carol Ruiz, Pilar Sánchez Chamero, Pere Blanch Gràcia, Alberto Cabestrero de Diego, Manuel Gomez Choco, Román Freixa Pamias

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1
Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?

Merce Faraudo, Paola Beltran, Román Freixa Pamias, Elisabet Mena Sebastià, Olga Guri, Anna Contra, Luís Miguel Ceresuela, Josep Masip

European Cardiology Review 2017;12(2):92–111.

DOI: https://doi.org/10.15420/ecr.2017:23:1

Pages